When a Genomic Panel Changes Nothing

You have the report. It is thick, it is color-coded, and somebody used the word remarkable about it.

Then you got home, opened it again, and realized nothing about Monday morning had changed.

That happens more than anyone admits. Not because genomic testing is junk. Because it got run at the wrong point in the order.

What do parents ask me most about this?

Short answers first. The full reasoning is below.

Why didn't my child's genomic panel change the plan?

A genomic panel often changes nothing on its own because it describes how a child's body is built, not how it is doing right now.

What labs do I run before a genomic panel?

Before a genomic panel I run conventional blood work. Ferritin with iron studies. 25-OH vitamin D. B12. A full thyroid panel.

Why does ferritin come before genomics?

Ferritin comes before genomics because ferritin is the number that tells me how much iron a child has in storage, and low storage iron shows up long before anemia does.

What does 25-OH vitamin D tell me that a gene cannot?

25-OH vitamin D tells me how much vitamin D a child actually has on board today. A gene can tell me that a child may handle vitamin D less efficiently.

Why check B12 and thyroid in a child who is struggling?

I check B12 and a full thyroid panel because both can look exactly like a behavior problem from the outside.

What does a genomic panel answer, and what does blood work answer?

A genomic panel answers what your child's body tends to do over a lifetime. Blood work answers what your child's body is doing this month.

When is a genomic panel worth ordering?

A genomic panel is worth ordering in two situations. The first is when there is a real diagnostic question, such as unexplained developmental delay, and a clinical sequencing test could name a cause.

What is a variant of uncertain significance?

A variant of uncertain significance is a genetic finding that laboratories cannot yet classify as harmful or harmless.

Why didn't my child's genomic panel change the plan?

A genomic panel often changes nothing on its own because it describes how a child's body is built, not how it is doing right now. It shows tendencies in pathways like folate handling, detox and inflammation. It does not show how much iron he is carrying today, where his vitamin D sits, or whether his thyroid is keeping up.

Those are two different questions. A genomic panel answers a lifetime question. Blood work answers a this-week question. The plan I write is built out of this-week numbers, and then genomics tells me how to shape it.

So if you paid for a genomic panel and walked out with a fascinating report and no decision, you were not sold something worthless. You were given the second step first.

What labs do I run before a genomic panel?

Before a genomic panel I run conventional blood work. Ferritin with iron studies. 25-OH vitamin D. B12. A full thyroid panel. Zinc and copper, read as a ratio rather than as two separate numbers. Five ordinary measurements that most children with focus, mood or sleep struggles have never had.

I run those first for one reason. Every one of them is a number I can move, and every one of them changes how a child feels while it moves. That is not true of a gene.

I draw this through Quest or through Children's Nebraska, and I read the numbers against what is normal for a child rather than against an adult range. That distinction matters more than most families are told.

Why does ferritin come before genomics?

Ferritin comes before genomics because ferritin is the number that tells me how much iron a child has in storage, and low storage iron shows up long before anemia does. A child can have a completely normal blood count and still be running on empty. The American Academy of Pediatrics names ferritin as part of how iron status gets assessed in young children.5

Storage iron matters for attention because iron sits inside the machinery the brain uses to make its chemical messengers. When it runs low, children get tired, foggy and short-fused before anything shows up on a standard panel.

A meta-analysis of iron supplementation in people who were low but not anemic found improvements in anxiety, fatigue and short-term memory, and no improvement in attention.6 I want you to see both halves of that. The honest read is that iron is worth measuring and worth correcting, and that correcting it is not the whole answer to attention.

Ferrochel, an iron bisglycinate, is the form I reach for when a child needs iron, because the high-dose prescription iron salts are hard on the gut. That is a form decision, and it belongs in a plan written for your child, not on a page.

If attention is the reason you are reading this, natural ADHD support for children is where the rest of that workup lives.

What does 25-OH vitamin D tell me that a gene cannot?

25-OH vitamin D tells me how much vitamin D a child actually has on board today. A gene can tell me that a child may handle vitamin D less efficiently. It cannot tell me the number. Only the blood test does that, and the number is what I act on.

It is worth measuring because low is common. In a national sample of more than 6,000 US children and young people, 9 percent were deficient and 61 percent were insufficient.7 That is not a rare finding I go hunting for. That is most of the waiting room.

Vitamin D3 with K2 in drop form is one of the foundational supports I use, and I use it against a number, not against a hunch.

Why check B12 and thyroid in a child who is struggling?

I check B12 and a full thyroid panel because both can look exactly like a behavior problem from the outside. Low B12 in young children can show up as delay, low muscle tone and feeding trouble, and it responds to correction when it is caught early.8 Thyroid sets the pace of a child's whole system, including energy, growth and the ability to hold attention.

Neither one is exotic. Both are cheap. Both get skipped constantly, because when a child has a behavior label, the questions stop being medical questions.

This is the part where I want to say something plainly. You were not being difficult when you asked whether something physical was going on. You were asking the right question, and you were asking it before anyone measured anything.

What does a genomic panel answer, and what does blood work answer?

A genomic panel answers what your child's body tends to do over a lifetime. Blood work answers what your child's body is doing this month. Genomics shapes the plan. Blood work builds it. Running them in the other order produces an interesting document and no decision.

What does it measure?

Genomic panel (IntellxxDNA, GeneDx): How your child's body is built to handle folate, detox, inflammation and nutrient processing

Basic blood work (Quest, Children's Nebraska): Ferritin and iron studies, 25-OH vitamin D, B12, thyroid panel, zinc and copper as a ratio

Does the result change over time?

Genomic panel (IntellxxDNA, GeneDx): No. It is the same at 4 and at 40.

Basic blood work (Quest, Children's Nebraska): Yes. That is the point. It moves when something is fixed.

Can it tell me why my child feels bad this month?

Genomic panel (IntellxxDNA, GeneDx): No

Basic blood work (Quest, Children's Nebraska): Often, yes

Does it produce a decision on its own?

Genomic panel (IntellxxDNA, GeneDx): Rarely. It modifies a decision made from something else.

Basic blood work (Quest, Children's Nebraska): Frequently. A low number is a thing to correct.

How is the sample collected?

Genomic panel (IntellxxDNA, GeneDx): Cheek swab, no needle

Basic blood work (Quest, Children's Nebraska): Blood draw

Where does it belong in the order?

Genomic panel (IntellxxDNA, GeneDx): After the basics are measured, or when a diagnostic question needs answering

Basic blood work (Quest, Children's Nebraska): First, almost always

Book My Free 15-Minute Call · or call 402-988-1873 Free. No obligation. Not a sales call.

When is a genomic panel worth ordering?

A genomic panel is worth ordering in two situations. The first is when there is a real diagnostic question, such as unexplained developmental delay, and a clinical sequencing test could name a cause. The second is after the basic numbers are known, when I want to know how to shape supports a child will use for years.

The first situation is not a fringe idea. A consensus review found that exome sequencing produced a molecular diagnosis in about 36 percent of people with unexplained neurodevelopmental differences, well above chromosomal microarray, and recommended putting it early in that evaluation.1 The American College of Medical Genetics and Genomics reached the same place in its clinical guideline.2 That is a diagnostic test, and it usually runs through genetics or neurology, not through me.

The second situation is where IntellxxDNA sits, and it is a different job from the diagnostic one GeneDx does. Those two are not the same test and they do not answer the same question, which is a whole subject on its own. How I use each one sits on my page about pediatric genomic testing.

These genetic findings are not diagnoses. They simply identify areas where a child's body benefits from extra support throughout his life.

What is a variant of uncertain significance?

A variant of uncertain significance is a genetic finding that laboratories cannot yet classify as harmful or harmless. It is one of five official categories, along with pathogenic, likely pathogenic, likely benign and benign, set out in the joint standards used by clinical genetics laboratories.3 It means the evidence is not in yet.

Families are rarely told how ordinary these are. A report can be full of them. They are not findings to build a plan on, and they are not findings to lose sleep over.

When a report is mostly uncertain findings and my patient has never had a ferritin drawn, the report is not the problem. The order is.

Should I run a genomic panel before my child starts a medication?

Usually no, and not because the science is bad. For a small and specific set of gene and drug pairs, a panel can tell a prescriber that a standard dose is likely to be wrong. That is real. It is also narrow enough that it rarely changes what happens on the day a child starts a medication.

Here is the size of it. The group that writes the peer-reviewed guidelines in this area had published 23 of them, covering 19 genes and 46 drugs, after its first ten years.4 Forty-six drugs is a meaningful list. It is not every drug, and it is often not the medication in front of you.

Prescribing decisions for your child's medications belong with the prescriber who wrote them. I do not change or stop another clinician's prescription based on a pathway report, and neither should anyone else.

What do I do with a genomic report that changed nothing?

I keep it. A genomic report that changed nothing on the day it arrived is usually a report waiting for its numbers. Once I have ferritin, 25-OH vitamin D, B12, thyroid and the zinc to copper ratio in front of me, the same report starts doing the job it was built for. It stops being a summary and starts being a modifier.

Here is what that looks like in practice. Blood work says a child needs folate support. The genomic report says his body moves folate poorly, so I choose an active form, methylfolate, instead of a synthetic one, and I start low and go slow. The decision came from the blood. The shape of the decision came from the genes.

That is the whole relationship, and it only works in that order.

You did not waste your money. You bought a good map of the territory before anyone had checked the weather. Both are useful. They are just not interchangeable, and one of them is free at almost any lab your pediatrician already uses.

If you want to see how the rest of this fits together, what a natural pediatrician does walks through the method from the start.

Start with the five numbers. Get them on paper. Then bring me the genomic report, and I will tell you what it actually changes, which is often less than you were promised and more useful than you expected. Your son is not a pathway chart. He is a kid who deserves to have someone check the simple things first.

Book My Free 15-Minute Call · or call 402-988-1873 Free. No obligation. Not a sales call.

Families work with me for pediatric functional medicine in Omaha in person, and by telehealth in Nebraska, Arizona, Colorado, Iowa, Tennessee and Virginia.

Written by Dr. Amy Patton, Founder Happy Kid Functional Medicine

Book My Free 15-Minute Call

Get Clarity and Learn More.

About the author

This article was written by Dr. Amy Patton, DNP, APRN, CPNP-PC, FMACP, a board-certified pediatric nurse practitioner and functional medicine provider serving Omaha-area families through Happy Kid Functional Medicine. Dr. Patton specializes in root-cause pediatric care for children's gut health, sleep, behavior, nutrition, immune patterns, and whole-child wellness. She sees patients in person in Omaha and by telehealth across Arizona, Colorado, Iowa, Nebraska, Tennessee, and Virginia.

References

1. Srivastava S, Love-Nichols JA, Dies KA, Ledbetter DH, Martin CL, Chung WK, et al. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genetics in Medicine. 2019;21(11):2413–2421. doi:10.1038/s41436-019-0554-6 PubMed

2. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 2021;23(11):2029–2037. doi:10.1038/s41436-021-01242-6 PubMed

3. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine. 2015;17(5):405–424. doi:10.1038/gim.2015.30 PubMed

4. Relling MV, Klein TE, Gammal RS, Whirl-Carrillo M, Hoffman JM, Caudle KE. The Clinical Pharmacogenetics Implementation Consortium: 10 years later. Clinical Pharmacology & Therapeutics. 2020;107(1):171–175. doi:10.1002/cpt.1651 PubMed

5. Baker RD, Greer FR; Committee on Nutrition, American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 2010;126(5):1040–1050. doi:10.1542/peds.2010-2576 PubMed

6. Fiani D, Chahine S, Zaboube M, Solmi M, Powers JM, Calarge C. Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: a meta-analysis and systematic review. Neuroscience & Biobehavioral Reviews. 2025;178:106372. doi:10.1016/j.neubiorev.2025.106372 PubMed

7. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics. 2009;124(3):e362–e370. doi:10.1542/peds.2009-0051 PubMed

8. Pancheva R, Dzhogova M, Dimitrov L, Nikolova M, Mihaylova G, Panayotova V, et al. Vitamin B12 deficiency in the diagnostic work-up of global developmental delay: a treatable and time-sensitive condition. Nutrients. 2026;18(7):1098. doi:10.3390/nu18071098 PubMed

Medical disclaimer: This article is educational and is not medical advice. It does not diagnose, treat, or replace individualized care from your child's pediatrician or licensed medical provider. Supplement types, doses, and combinations should be selected with a qualified clinician who knows your child's full history — never start a new supplement based on a blog post alone. Always consult your pediatrician before making changes to your child's routine, and seek prompt medical care for snoring with gasping or pauses in breathing during sleep, or for any severe, sudden, or concerning symptom. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.